Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “targeted”

263 pharma patents match "targeted" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 263
Index total 30,257
Page 9 / 11

Quick answer

This filtered view shows 263 pharmaceutical patents matching "targeted" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

263 results for “targeted” · 30,257 patents in full index Clear search

  1. US 9200266

    Methods and compositions for targeted single-stranded cleavage and targeted integration

    Sangamo Biosciences, Inc. · Granted Dec 1, 2015 · Expires Nov 26, 2035

    granted

  2. US 9180161

    CAR peptide for homing, diagnosis and targeted therapy for pulmonary and fibrotic disorders

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Nov 10, 2015 · Expires Nov 5, 2035

    granted

  3. US 9169495

    Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Oct 27, 2015 · Expires Oct 22, 2035

    granted

  4. US 9095624

    Modular transport platform for targeted delivery of therapeutic agents

    Contango Partners Group, Inc. · Granted Aug 4, 2015 · Expires Jul 30, 2035

    granted

  5. US 9034829

    pH-sensitive polymer-drug conjugates for targeted delivery of therapeutics

    Northwestern University · Granted May 19, 2015 · Expires May 14, 2035

    granted

  6. US 9011919

    Compositions for targeted delivery of siRNA

    Arrowhead Madison, Inc. · Granted Apr 21, 2015 · Expires Apr 16, 2035

    granted

  7. US 8986701

    Enzyme prodrug cancer therapy selectively targeted to tumor vasculature and methods of production and use thereof

    The Board of Regents of the University of Oklahoma · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted

  8. US 8980275

    Targeted heterologous antigen presentation on calicivirus virus-like particles

    Takeda Vaccines, Inc. · Granted Mar 17, 2015 · Expires Mar 12, 2035

    granted

  9. US 8956828

    Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases

    Sangamo Biosciences, Inc. · Granted Feb 17, 2015 · Expires Feb 12, 2035

    granted

  10. US 8916606

    Therapeutic compositions and methods for targeted delivery of active agents

    The Board of Regents of the University of Texas System · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted

  11. US 8906343

    PAA nanoplatforms containing fluorophores and targeted moieties covalently linked and photosensitizer post-loaded

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 9, 2014 · Expires Dec 4, 2034

    granted

  12. US 8889644

    GNAQ targeted dsRNA compositions and methods for inhibiting expression

    Alnylam Pharmaceuticals, Inc. · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted

  13. US 8859498

    Targeted therapeutic proteins

    BIOMARIN PHARMACEUTICAL INC. · Granted Oct 14, 2014 · Expires Oct 9, 2034

    granted

  14. US 8840868

    Non-invasive detection of complement-mediated inflammation using CR2-targeted nanoparticles

    The Regents of the University of Colorado, a Body Corporate · Granted Sep 23, 2014 · Expires Sep 18, 2034

    granted

  15. US 8822221

    Targeted integration into the PPP1R12C locus

    Sangamo Biosciences, Inc. · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  16. US 8821943

    Methods and compositions for targeted delivery of therapeutic agents

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Sep 2, 2014 · Expires Aug 28, 2034

    granted

  17. US 8772013

    Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted

  18. US 8759301

    Gene fusion targeted therapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted

  19. US 8740872

    Magnetically-targeted treatment for cardiac disorders

    The Board of Regents of the University of Oklahoma · Granted Jun 3, 2014 · Expires May 29, 2034

    granted

  20. US 8703134

    Targeted cryptosporidium biocides

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  21. US 8703489

    Methods and compositions for targeted single-stranded cleavage and targeted integration

    Sangamo Biosciences, Inc. · Granted Apr 22, 2014 · Expires Apr 17, 2034

    granted

  22. US 8685932

    Targeted transforming growth factor-beta-bound IgG for Treatment of Diseases

    OPTION PHARMACEUTICALS, LLC · Granted Apr 1, 2014 · Expires Mar 27, 2034

    granted

  23. US 8680058

    Selectively targeted antimicrobial peptides and the use thereof

    The Regents of the University of California · Granted Mar 25, 2014 · Expires Mar 20, 2034

    granted

  24. US 8591862

    Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells

    EnGeneIC Molecular Delivery Pty Ltd · Granted Nov 26, 2013 · Expires Nov 21, 2033

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.